FDA Inspection
Tissue Banks International IncTissue Banks International Inc – FDA Inspection, Sep 21, 2010
Record Details
This FDA Inspection record concerns Tissue Banks International Inc, with an inspection on September 21, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- September 21, 2010
- Product Type
- Biologics
View Company Profile
ID · ace6dfbe-dcda-4dbe-88a7-1b905f0f9b10
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 679602
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.265(f)Return to inventory--procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tissue Banks International Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 26, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 11, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Tissue Banks International Inc
- FDA Inspection 983208 - 2016-05-26
- FDA Inspection 786666 - 2012-05-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.